Abstract
We report an optimized synthesis of the acyclic pyridine-hexaacetate chelator H6aPyha and demonstrate its instantaneous room-temperature radiolabeling with lead radionuclides (>95%), yielding a complex with remarkable kinetic inertness in blood serum (>90% over 48 h). Combined spectroscopic and computational studies reveal that the complex possesses a highly fluxional, asymmetric coordination environment, balancing structural adaptability during metal ion uptake with robust subsequent encapsulation. The results show that H6aPyha provides a highly desirable dual-affinity platform capable of retaining both the parent 212Pb and daughter 212Bi isotopes, making it an important advancement for targeted alpha therapy.
Keywords
acyclic chelators
conformational fluxionality
DFT calculations
lead radionuclides
serum stability
solution coordination chemistry
targeted alpha therapy
Funders
Russian Science Foundation
23-13-00424-P
Ministry of Education and Science of the Russian Federation
075-03-2026-024